Financial Ratios GE HealthCare Technologies Inc.

Stocks

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 01:11:23 2026-06-11 pm EDT			5-day change	1st Jan Change
63.50 ^USD	-0.42%		-0.56%	-22.63%

Jun. 04	GE HealthCare Receives FDA 510(k) Clearance For MIM Contour ProtégéAI+ 2.0	CI
Jun. 04	GE HealthCare Gets FDA Clearance for AI-Powered Radiation Therapy Planning Software	MT

7fe02b0.hjJPJH2fImmylKCbSBI_eGbGrHlEz31rapDCBTGTqek.6GI3QR6nRj2fxpH0OmppEQ3z7SEGrUsJW8COSAC-8LvCcwdiGNZbG_TRkA

Published financial data: GE HEALTHCARE TECHNOLOGIES INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	17.58B	18.34B	19.55B	19.67B	20.62B
Total Revenues	17.58B	18.34B	19.55B	19.67B	20.62B
Cost of Goods Sold, Total	10.41B	11.16B	11.63B	11.47B	12.38B
Gross Profit	7.17B	7.18B	7.92B	8.2B	8.25B
Selling General & Admin Expenses, Total	3.56B	3.62B	3.91B	3.87B	3.92B
R&D Expenses	816M	1.03B	1.2B	1.31B	1.26B
Other Operating Expenses, Total	4.38B	4.65B	5.11B	5.18B	5.18B
Operating Income	2.79B	2.53B	2.81B	3.03B	3.06B
Interest Expense, Total	-40M	-86M	-505M	-463M	-381M
Interest And Investment Income	34M	-	26M	-	41M
Net Interest Expenses	-6M	-86M	-479M	-463M	-340M
Income (Loss) On Equity Invest.	27M	13M	11M	8M	3M
Currency Exchange Gains (Loss)	-	-	-37M	-42M	-59M
Other Non Operating Income (Expenses)	60M	53M	38M	34M	7M
EBT, Excl. Unusual Items	2.88B	2.51B	2.34B	2.56B	2.68B
Gain (Loss) On Sale Of Investments	-	-	-	-	97M
Other Unusual Items	-	-	17M	18M	-4M
EBT, Incl. Unusual Items	2.88B	2.51B	2.36B	2.58B	2.77B
Income Tax Expense	600M	563M	743M	531M	614M
Earnings From Continuing Operations	2.28B	1.95B	1.62B	2.05B	2.15B
Earnings Of Discontinued Operations	18M	18M	-4M	-	-
Net Income to Company	2.29B	1.97B	1.61B	2.05B	2.15B
Minority Interest	-46M	-51M	-229M	-57M	-70M
Net Income - (IS)	2.25B	1.92B	1.38B	1.99B	2.08B
Net Income to Common Incl Extra Items	2.25B	1.92B	1.38B	1.99B	2.08B
Net Income to Common Excl. Extra Items	2.23B	1.9B	1.39B	1.99B	2.08B
Per Share Items
Net EPS - Basic	-	-	3.04	4.37	4.57
Basic EPS - Continuing Operations	-	-	3.05	4.37	4.57
Basic Weighted Average Shares Outstanding	-	-	455M	456M	456M
Net EPS - Diluted	-	-	3.03	4.34	4.55
Diluted EPS - Continuing Operations	-	-	3.04	4.34	4.55
Diluted Weighted Average Shares Outstanding	-	-	458M	459M	458M
Normalized Basic EPS	-	-	2.72	3.39	3.51
Normalized Diluted EPS	-	-	2.7	3.37	3.5
Dividend Per Share	-	-	0.12	0.12	0.14
Payout Ratio	-	-	2.96	2.76	3.07
Supplemental Items
EBITDA	3.42B	3.16B	3.42B	3.61B	3.64B
EBITA	3.19B	2.94B	3.17B	3.34B	3.36B
EBIT	2.79B	2.53B	2.81B	3.03B	3.06B
EBITDAR	3.6B	3.38B	3.65B	3.86B	3.89B
Total Revenues (As Reported)	17.58B	18.34B	19.55B	19.67B	20.62B
Effective Tax Rate - (Ratio)	20.87	22.41	31.47	20.57	22.18
Current Domestic Taxes	196M	493M	213M	70M	12M
Current Foreign Taxes	422M	324M	345M	412M	317M
Total Current Taxes	618M	817M	558M	482M	329M
Deferred Domestic Taxes	83M	-261M	82M	61M	154M
Deferred Foreign Taxes	-101M	7M	103M	-12M	131M
Total Deferred Taxes	-18M	-254M	185M	49M	285M
Normalized Net Income	1.75B	1.52B	1.24B	1.54B	1.6B
Interest on Long-Term Debt	-	-	616M	580M	540M
Non-Cash Pension Expense	1M	-10M	-301M	-325M	-206M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	816M	1.03B	1.2B	1.31B	1.26B
Net Rental Expense, Total	185M	217M	229M	258M	249M
Imputed Operating Lease Interest Expense	1.64B	32.91M	100M	99.34M	76.51M
Imputed Operating Lease Depreciation	-1.46B	184M	129M	159M	172M
Stock-Based Comp., Other (Total)	-	-	114M	125M	130M
Total Stock-Based Compensation	-	-	114M	125M	130M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	556M	1.44B	2.49B	2.87B	4.49B
Total Cash And Short Term Investments	556M	1.44B	2.49B	2.87B	4.49B
Accounts Receivable, Total	3.66B	3.6B	3.84B	3.87B	4.26B
Other Receivables	-	291M	316M	406M	493M
Notes Receivable	99M	97M	97M	90M	95M
Total Receivables	3.76B	3.99B	4.25B	4.36B	4.85B
Inventory	1.95B	2.16B	1.96B	1.94B	2.23B
Prepaid Expenses	163M	163M	147M	188M	227M
Restricted Cash	-	5M	10M	16M	20M
Other Current Assets, Total	576M	562M	545M	522M	679M
Total Current Assets	7B	8.32B	9.41B	9.9B	12.5B
Gross Property Plant And Equipment	5.05B	5.3B	5.56B	5.63B	6.14B
Accumulated Depreciation	-2.82B	-2.99B	-3.06B	-3.08B	-3.05B
Net Property Plant And Equipment	2.24B	2.31B	2.5B	2.55B	3.09B
Long-term Investments	341M	322M	357M	373M	351M
Goodwill	12.89B	12.81B	12.94B	13.14B	13.49B
Other Intangibles, Total	1.85B	1.52B	1.25B	1.08B	1.13B
Accounts Receivable Long-Term	19M	86M	168M	208M	211M
Loans Receivable Long-Term	186M	196M	178M	183M	190M
Deferred Tax Assets Long-Term	1.29B	1.55B	4.47B	4.47B	4.49B
Deferred Charges Long-Term	77M	82M	-	-	200M
Other Long-Term Assets, Total	424M	338M	1.18B	1.19B	1.25B
Total Assets	26.31B	27.54B	32.45B	33.09B	36.91B
Liabilities
Accounts Payable, Total	2.54B	2.94B	2.95B	3.02B	3.25B
Accrued Expenses, Total	-	1.33B	1.99B	2.04B	2.23B
Short-term Borrowings	-	-	1.01B	2M	6M
Current Portion of Long-Term Debt	6M	15M	-	1.5B	502M
Current Portion of Leases	-	104M	110M	115M	134M
Current Income Taxes Payable	-	-	-	279M	324M
Unearned Revenue Current, Total	1.86B	1.9B	1.92B	1.94B	2.1B
Other Current Liabilities	2.35B	899M	1.01B	657M	564M
Total Current Liabilities	6.76B	7.19B	8.98B	9.55B	9.1B
Long-Term Debt	31M	8.23B	8.44B	7.45B	9.5B
Long-Term Leases	-	282M	311M	310M	326M
Unearned Revenue Non Current	-	630M	705M	687M	803M
Pension & Other Post Retirement Benefits	751M	549M	5.78B	5.58B	5.45B
Deferred Tax Liability Non Current	385M	370M	68M	56M	193M
Other Non Current Liabilities	1.48B	691M	861M	799M	932M
Total Liabilities	9.41B	17.95B	25.14B	24.44B	26.31B
Common Stock, Total	17.69B	11.24B	5M	5M	5M
Additional Paid In Capital	-	-	6.49B	6.58B	6.71B
Retained Earnings	-	-	1.33B	3.26B	5.28B
Treasury Stock	-	-	-	-25M	-225M
Comprehensive Income and Other	-1.04B	-1.88B	-691M	-1.38B	-1.39B
Total Common Equity	16.66B	9.36B	7.13B	8.45B	10.38B
Minority Interest	241M	235M	177M	206M	220M
Total Equity	16.9B	9.59B	7.31B	8.65B	10.6B
Total Liabilities And Equity	26.31B	27.54B	32.45B	33.09B	36.91B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	454M	455M	457M	456M
ECS Total Common Shares Outstanding	-	-	455M	457M	456M
Book Value / Share	-	-	15.67	18.48	22.77
Tangible Book Value	1.92B	-4.98B	-7.06B	-5.77B	-4.24B
Tangible Book Value Per Share	-	-	-15.5	-12.62	-9.3
Total Debt	37M	8.64B	9.86B	9.38B	10.46B
Net Debt	-519M	7.2B	7.37B	6.5B	5.97B
Debt Equivalent of Unfunded Proj. Benefit Obligation	387M	278M	3.53B	3.54B	3.46B
Debt Equivalent Oper. Leases	1.48B	1.74B	1.83B	2.06B	1.99B
Minority Interest, Total (Incl. Fin. Div)	241M	235M	177M	206M	220M
Equity Method Investments, Total	341M	322M	357M	373M	351M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	900M	1.05B	961M	921M	1B
Inventories - Work In Process, Total	104M	91M	91M	92M	95M
Inventories - Finished Goods, Total	942M	1.01B	908M	926M	1.14B
Land - (BS)	77M	70M	70M	66M	144M
Buildings, Total	1.76B	1.89B	1.96B	1.94B	2.14B
Machinery, Total	2.47B	2.54B	2.62B	2.7B	2.87B
Full Time Employees	51K	50K	51K	53K	54K
Accumulated Allowance for Doubtful Accounts (Supple)	107M	91M	98M	103M	103M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.25B	1.92B	1.38B	1.99B	2.08B
Depreciation & Amortization - CF	225M	228M	248M	268M	287M
Amortization of Goodwill and Intangible Assets - (CF)	400M	405M	362M	312M	291M
Depreciation & Amortization, Total	625M	633M	610M	580M	578M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-97M
Stock-Based Compensation (CF)	-	-	114M	125M	130M
Net Cash From Discontinued Operations	-	-21M	-	-4M	-
Other Operating Activities, Total	13M	-320M	-204M	-610M	-351M
Change In Accounts Receivable	-1.31B	-453M	-175M	-175M	-276M
Change In Inventories	-435M	-402M	111M	-81M	-142M
Change In Accounts Payable	263M	481M	-13M	126M	90M
Change in Unearned Revenues	-21M	138M	26M	68M	81M
Change in Other Net Operating Assets	228M	141M	247M	-71M	-110M
Cash from Operations	1.61B	2.11B	2.1B	1.95B	1.99B
Capital Expenditure	-242M	-310M	-387M	-401M	-482M
Sale of Property, Plant, and Equipment	15M	4M	1M	-	-
Cash Acquisitions	-1.48B	-	-147M	-313M	-378M
Sale (Purchase) of Intangible assets	-6M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-40M	-118M
Other Investing Activities, Total	-47M	-92M	-25M	-160M	-69M
Cash from Investing	-1.76B	-398M	-558M	-914M	-1.05B
Short Term Debt Issued, Total	-	9M	-	-	1M
Long-Term Debt Issued, Total	5M	8.2B	2.01B	995M	2.73B
Total Debt Issued	5M	8.21B	2.01B	995M	2.74B
Short Term Debt Repaid, Total	-7M	-	-12M	-	-
Long-Term Debt Repaid, Total	-10M	-3M	-855M	-1.42B	-1.77B
Total Debt Repaid	-17M	-3M	-867M	-1.42B	-1.77B
Issuance of Common Stock	-	-	-	33M	37M
Repurchase of Common Stock	-	-	-	-93M	-242M
Common Dividends Paid	-	-	-41M	-55M	-64M
Common & Preferred Stock Dividends Paid	-	-	-41M	-55M	-64M
Other Financing Activities, Total	-251M	-9.03B	-1.58B	-35M	-81M
Cash from Financing	-263M	-822M	-478M	-573M	618M
Foreign Exchange Rate Adjustments	-34M	-3M	-10M	-77M	66M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-2M
Net Change in Cash	-451M	890M	1.06B	387M	1.62B
Supplemental Items
Cash Interest Paid	21M	-	570M	550M	522M
Cash Income Tax Paid (Refund)	-	-	474M	491M	429M
Levered Free Cash Flow	778M	1.84B	2.53B	1.86B	1.45B
Unlevered Free Cash Flow	803M	1.89B	2.85B	2.15B	1.69B
Change In Net Working Capital	1.32B	11M	-755M	41M	454M
Net Debt Issued / Repaid	-12M	8.2B	1.14B	-423M	968M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.91	5.88	5.86	5.77	5.47
Return on Total Capital	10.93	8.9	9.93	10.75	9.8
Return On Equity %	14.28	14.72	19.15	25.69	22.38
Return on Common Equity	14.21	14.59	16.85	25.59	22.14
Margin Analysis
Gross Profit Margin %	40.8	39.14	40.52	41.71	39.99
SG&A Margin	20.27	19.74	19.98	19.66	19.02
EBITDA Margin %	19.44	17.26	17.5	18.33	17.66
EBITA Margin %	18.16	16.01	16.23	16.97	16.27
EBIT Margin %	15.89	13.81	14.38	15.38	14.86
Income From Continuing Operations Margin %	12.94	10.63	8.28	10.42	10.44
Net Income Margin %	12.78	10.45	7.08	10.13	10.1
Net Avail. For Common Margin %	12.68	10.35	7.1	10.13	10.1
Normalized Net Income Margin	9.96	8.28	6.32	7.85	7.77
Levered Free Cash Flow Margin	4.43	10.04	12.96	9.48	7.02
Unlevered Free Cash Flow Margin	4.57	10.33	14.57	10.95	8.18
Asset Turnover
Asset Turnover	0.7	0.68	0.65	0.6	0.59
Fixed Assets Turnover	7.93	8.06	8.12	7.79	7.31
Receivables Turnover (Average Receivables)	5.85	5.27	5.25	5.1	5.08
Inventory Turnover (Average Inventory)	5.88	5.44	5.65	5.88	5.93
Short Term Liquidity
Current Ratio	1.04	1.16	1.05	1.04	1.37
Quick Ratio	0.62	0.74	0.74	0.75	1.02
Operating Cash Flow to Current Liabilities	0.24	0.29	0.23	0.2	0.22
Days Sales Outstanding (Average Receivables)	62.42	69.24	69.5	71.7	71.92
Days Outstanding Inventory (Average Inventory)	62.05	67.05	64.57	62.22	61.53
Average Days Payable Outstanding	79.73	88.02	94.02	95.43	90.51
Cash Conversion Cycle (Average Days)	44.75	48.28	40.06	38.49	42.94
Long Term Solvency
Total Debt/Equity	0.22	90.02	134.92	108.37	98.72
Total Debt / Total Capital	0.22	47.37	57.43	52.01	49.68
LT Debt/Equity	0.18	88.78	119.66	89.68	92.66
Long-Term Debt / Total Capital	0.18	46.72	50.93	43.04	46.63
Total Liabilities / Total Assets	35.78	65.17	77.48	73.85	71.28
EBIT / Interest Expense	69.85	29.44	5.57	6.54	8.04
EBITDA / Interest Expense	85.48	39.33	7.23	8.35	10.21
(EBITDA - Capex) / Interest Expense	79.42	35.72	6.46	7.48	8.95
Total Debt / EBITDA	0.01	2.55	2.7	2.43	2.69
Net Debt / EBITDA	-0.15	2.13	2.02	1.68	1.53
Total Debt / (EBITDA - Capex)	0.01	2.81	3.02	2.71	3.07
Net Debt / (EBITDA - Capex)	-0.16	2.34	2.26	1.88	1.75
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	2.45	4.3	6.6	0.61	4.84
Gross Profit, 1 Yr. Growth %	6.01	0.07	10.35	3.57	0.51
EBITDA, 1 Yr. Growth %	2.18	-7.43	10.35	5.41	0.47
EBITA, 1 Yr. Growth %	2.24	-8.05	10.48	5.2	-0.06
EBIT, 1 Yr. Growth %	2.87	-9.38	13.94	7.65	0.62
Earnings From Cont. Operations, 1 Yr. Growth %	10.54	-14.33	-16.98	26.7	5.07
Net Income, 1 Yr. Growth %	-83.77	-14.73	-27.71	43.9	4.57
Normalized Net Income, 1 Yr. Growth %	6.58	-13.24	-16.39	24.99	2.9
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-27.27	42.76	4.84
Accounts Receivable, 1 Yr. Growth %	55.41	7.48	6.55	0.68	10.19
Inventory, 1 Yr. Growth %	22.08	10.74	-9.05	-1.07	15.21
Net Property, Plant and Equip., 1 Yr. Growth %	1.5	3.53	8.04	2	21.25
Total Assets, 1 Yr. Growth %	8.59	4.68	17.85	1.96	11.54
Tangible Book Value, 1 Yr. Growth %	52.55	-359.71	41.8	-18.25	-26.49
Common Equity, 1 Yr. Growth %	13.09	-43.82	-23.77	18.41	22.89
Cash From Operations, 1 Yr. Growth %	-4.74	31.49	-0.57	-7.14	1.85
Capital Expenditures, 1 Yr. Growth %	2.11	28.1	24.84	3.62	20.2
Levered Free Cash Flow, 1 Yr. Growth %	-	173.82	35.68	-26.38	-22.8
Unlevered Free Cash Flow, 1 Yr. Growth %	-	171.71	48.31	-24.38	-22.12
Dividend Per Share, 1 Yr. Growth %	-	-	-	4.17	12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	2.82	3.37	5.44	3.56	2.71
Gross Profit, 2 Yr. CAGR %	4.67	3	5.08	6.91	2.03
EBITDA, 2 Yr. CAGR %	11	-2.74	0.03	7.85	2.92
EBITA, 2 Yr. CAGR %	11.92	-3.04	-0.33	7.81	2.55
EBIT, 2 Yr. CAGR %	14.91	-3.45	0.3	10.75	4.09
Earnings From Cont. Operations, 2 Yr. CAGR %	16.33	-2.68	-15.67	2.56	15.38
Net Income, 2 Yr. CAGR %	21.43	-62.8	-21.49	1.99	22.67
Normalized Net Income, 2 Yr. CAGR %	17.05	-3.84	-15.98	2.22	13.36
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-21.31	1.9	22.34
Accounts Receivable, 2 Yr. CAGR %	-	23.72	7.01	3.57	5.33
Inventory, 2 Yr. CAGR %	-	16.27	0.36	-5.14	6.76
Net Property, Plant and Equip., 2 Yr. CAGR %	-	2.51	5.76	4.98	11.21
Total Assets, 2 Yr. CAGR %	-	6.61	11.07	9.61	6.64
Tangible Book Value, 2 Yr. CAGR %	-	99.04	91.9	7.66	-22.48
Common Equity, 2 Yr. CAGR %	-	-20.29	-34.56	-4.99	20.63
Cash From Operations, 2 Yr. CAGR %	-10.11	11.92	14.34	-3.91	-2.75
Capital Expenditures, 2 Yr. CAGR %	-4.08	14.37	24.92	13.73	11.6
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	84	-0.06	-24.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	91.94	5.9	-23.19
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	8.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	3.31	4.44	3.81	3.99
Gross Profit, 3 Yr. CAGR %	-	3.11	5.39	4.58	4.73
EBITDA, 3 Yr. CAGR %	-	4.48	0.74	1.79	5.52
EBITA, 3 Yr. CAGR %	-	4.82	0.52	1.48	5.32
EBIT, 3 Yr. CAGR %	-	6.17	1.15	2.69	7.49
Earnings From Cont. Operations, 3 Yr. CAGR %	-	5.05	-7.71	-3.41	3.39
Net Income, 3 Yr. CAGR %	-	7.93	-53.58	-3.92	2.84
Normalized Net Income, 3 Yr. CAGR %	-	5.93	-9.05	-4.09	2.71
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-4.03	2.87
Accounts Receivable, 3 Yr. CAGR %	-	-	17.71	4.86	5.73
Inventory, 3 Yr. CAGR %	-	-	7.13	-0.12	1.21
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	4.32	4.49	10.14
Total Assets, 3 Yr. CAGR %	-	-	10.23	7.94	10.25
Tangible Book Value, 3 Yr. CAGR %	-	-	77.77	44.39	-5.2
Common Equity, 3 Yr. CAGR %	-	-	-21.47	-20.26	3.52
Cash From Operations, 3 Yr. CAGR %	-	2.04	7.59	6.68	-2.03
Capital Expenditures, 3 Yr. CAGR %	-	5.63	17.76	17.37	15.85
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	35.58	-8.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	40.71	-4.24
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	3.41	3.74
Gross Profit, 5 Yr. CAGR %	-	-	-	4.62	4.04
EBITDA, 5 Yr. CAGR %	-	-	-	5.38	1.71
EBITA, 5 Yr. CAGR %	-	-	-	5.53	1.44
EBIT, 5 Yr. CAGR %	-	-	-	7.42	2.44
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	4.05	0.92
Net Income, 5 Yr. CAGR %	-	-	-	5.51	-31.53
Normalized Net Income, 5 Yr. CAGR %	-	-	-	3.87	-0.5
Accounts Receivable, 5 Yr. CAGR %	-	-	-	-	12.59
Inventory, 5 Yr. CAGR %	-	-	-	-	6.98
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-	7.02
Total Assets, 5 Yr. CAGR %	-	-	-	-	8.78
Tangible Book Value, 5 Yr. CAGR %	-	-	-	-	27.55
Common Equity, 5 Yr. CAGR %	-	-	-	-	-6.76
Cash From Operations, 5 Yr. CAGR %	-	-	-	-0.39	3.33
Capital Expenditures, 5 Yr. CAGR %	-	-	-	8.8	15.26